#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=2 .
1-1	0-1	2	quantity	new	_	_
1-2	2-3	.	_	_	_	_

#Text=Mutations Induced along with Genomic Destabilization
2-1	4-13	Mutations	abstract	new	coref	11-1[65_0]
2-2	14-21	Induced	_	_	_	_
2-3	22-27	along	_	_	_	_
2-4	28-32	with	_	_	_	_
2-5	33-40	Genomic	abstract|event[4]	new|new[4]	coref|coref|coref|coref	14-14[101_4]|33-7|14-14[101_4]|33-7
2-6	41-56	Destabilization	event[4]	new[4]	_	_

#Text=2.1 .
3-1	57-60	2.1	abstract	new	_	_
3-2	61-62	.	_	_	_	_

#Text=Mutation Rate and Its
4-1	63-71	Mutation	abstract|abstract[7]|abstract[8]	new|new[7]|new[8]	ana|coref|coref|ana|coref|coref|ana|coref|coref	4-4[0_7]|8-3|10-6[47_8]|4-4[0_7]|8-3|10-6[47_8]|4-4[0_7]|8-3|10-6[47_8]
4-2	72-76	Rate	abstract[7]|abstract[8]	new[7]|new[8]	_	_
4-3	77-80	and	abstract[8]	new[8]	_	_
4-4	81-84	Its	abstract[8]|abstract	new[8]|giv	_	_

#Text=Association with Cancer Risk
5-1	85-96	Association	abstract[10]	new[10]	coref	10-3[44_10]
5-2	97-101	with	abstract[10]	new[10]	_	_
5-3	102-108	Cancer	abstract[10]|abstract|abstract[12]	new[10]|new|new[12]	coref|coref|coref|coref	9-15|9-27[43_12]|9-15|9-27[43_12]
5-4	109-113	Risk	abstract[10]|abstract[12]	new[10]|new[12]	_	_

#Text=In normal human cells , DNA is usually replicated by high-fidelity polymerases δ and ε .
6-1	114-116	In	_	_	_	_
6-2	117-123	normal	object[13]	new[13]	ana	7-10[0_13]
6-3	124-129	human	object[13]	new[13]	_	_
6-4	130-135	cells	object[13]	new[13]	_	_
6-5	136-137	,	_	_	_	_
6-6	138-141	DNA	substance	new	_	_
6-7	142-144	is	_	_	_	_
6-8	145-152	usually	_	_	_	_
6-9	153-163	replicated	_	_	_	_
6-10	164-166	by	_	_	_	_
6-11	167-180	high-fidelity	abstract[16]|abstract[17]	new[16]|new[17]	coref|coref	27-25[156_17]|27-25[156_17]
6-12	181-192	polymerases	object|abstract[16]|abstract[17]	new|new[16]|new[17]	coref	7-4[20_0]
6-13	193-194	δ	abstract[16]|abstract[17]	new[16]|new[17]	_	_
6-14	195-198	and	abstract[17]	new[17]	_	_
6-15	199-200	ε	abstract[17]|abstract	new[17]|new	coref	9-8[36_0]
6-16	201-202	.	_	_	_	_

#Text=Errors caused by those polymerases are primarily repaired by their proofreading system ( Table 1 ) , and the remaining errors are targeted by the mismatch repair ( MMR ) system .
7-1	203-209	Errors	abstract	new	coref	7-19[25_0]
7-2	210-216	caused	_	_	_	_
7-3	217-219	by	_	_	_	_
7-4	220-225	those	object[20]	giv[20]	coref	26-22[147_20]
7-5	226-237	polymerases	object[20]	giv[20]	_	_
7-6	238-241	are	_	_	_	_
7-7	242-251	primarily	_	_	_	_
7-8	252-260	repaired	_	_	_	_
7-9	261-263	by	_	_	_	_
7-10	264-269	their	object|abstract[23]	giv|new[23]	coref|coref|coref|coref	7-31[0_23]|10-45|7-31[0_23]|10-45
7-11	270-282	proofreading	organization|abstract[23]	new|new[23]	coref	9-5
7-12	283-289	system	abstract[23]	new[23]	_	_
7-13	290-291	(	_	_	_	_
7-14	292-297	Table	object[24]	new[24]	coref	26-26[148_24]
7-15	298-299	1	object[24]	new[24]	_	_
7-16	300-301	)	_	_	_	_
7-17	302-303	,	_	_	_	_
7-18	304-307	and	_	_	_	_
7-19	308-311	the	abstract[25]	giv[25]	coref	19-16[0_25]
7-20	312-321	remaining	abstract[25]	giv[25]	_	_
7-21	322-328	errors	abstract[25]	giv[25]	_	_
7-22	329-332	are	_	_	_	_
7-23	333-341	targeted	_	_	_	_
7-24	342-344	by	_	_	_	_
7-25	345-348	the	abstract[27]	new[27]	appos	7-29[0_27]
7-26	349-357	mismatch	abstract|abstract[27]	new|new[27]	_	_
7-27	358-364	repair	abstract[27]	new[27]	_	_
7-28	365-366	(	_	_	_	_
7-29	367-370	MMR	abstract	giv	coref	9-3
7-30	371-372	)	_	_	_	_
7-31	373-379	system	abstract	giv	_	_
7-32	380-381	.	_	_	_	_

#Text=Consequently , mutation is largely suppressed during normal replication .
8-1	382-394	Consequently	_	_	_	_
8-2	395-396	,	_	_	_	_
8-3	397-405	mutation	abstract	giv	coref	9-21
8-4	406-408	is	_	_	_	_
8-5	409-416	largely	_	_	_	_
8-6	417-427	suppressed	_	_	_	_
8-7	428-434	during	_	_	_	_
8-8	435-441	normal	abstract[31]	new[31]	coref	13-26[0_31]
8-9	442-453	replication	abstract[31]	new[31]	_	_
8-10	454-455	.	_	_	_	_

#Text=Deficiencies in MMR and proofreading performed by polymerase ε are associated with hypermutation and cancer predisposition ; thus , the mutation rate is strongly associated with cancer risk .
9-1	456-468	Deficiencies	abstract	new	_	_
9-2	469-471	in	_	_	_	_
9-3	472-475	MMR	abstract	giv	coref	26-19
9-4	476-479	and	_	_	_	_
9-5	480-492	proofreading	event	giv	coref	29-20
9-6	493-502	performed	_	_	_	_
9-7	503-505	by	_	_	_	_
9-8	506-516	polymerase	object|abstract[36]	new|giv[36]	coref|coref	27-27[0_36]|27-27[0_36]
9-9	517-518	ε	abstract[36]	giv[36]	_	_
9-10	519-522	are	_	_	_	_
9-11	523-533	associated	_	_	_	_
9-12	534-538	with	_	_	_	_
9-13	539-552	hypermutation	event|abstract[39]	new|new[39]	coref|coref	14-10|14-10
9-14	553-556	and	abstract[39]	new[39]	_	_
9-15	557-563	cancer	abstract|abstract[39]	giv|new[39]	coref	9-27
9-16	564-578	predisposition	abstract[39]	new[39]	_	_
9-17	579-580	;	_	_	_	_
9-18	581-585	thus	_	_	_	_
9-19	586-587	,	_	_	_	_
9-20	588-591	the	abstract[41]	new[41]	coref	10-6[46_41]
9-21	592-600	mutation	abstract|abstract[41]	giv|new[41]	coref	10-6
9-22	601-605	rate	abstract[41]	new[41]	_	_
9-23	606-608	is	_	_	_	_
9-24	609-617	strongly	_	_	_	_
9-25	618-628	associated	_	_	_	_
9-26	629-633	with	_	_	_	_
9-27	634-640	cancer	abstract|event[43]	giv|giv[43]	coref|coref|coref|coref	10-9|10-9[49_43]|10-9|10-9[49_43]
9-28	641-645	risk	event[43]	giv[43]	_	_
9-29	646-647	.	_	_	_	_

#Text=However , this association between mutation rate and cancer risk may be unrelated to cell division frequency and resultant changes in cell number , as aptly pointed out by Peto ’s paradox : cancer incidence does not appear to correlate with the number of cells in an organism at the species level .
10-1	648-655	However	_	_	_	_
10-2	656-657	,	_	_	_	_
10-3	658-662	this	abstract[44]	giv[44]	coref	18-30[115_44]
10-4	663-674	association	abstract[44]	giv[44]	_	_
10-5	675-682	between	abstract[44]	giv[44]	_	_
10-6	683-691	mutation	abstract[44]|abstract|abstract[46]|abstract[47]	giv[44]|giv|giv[46]|giv[47]	coref|coref|coref	12-12|12-12|12-12
10-7	692-696	rate	abstract[44]|abstract[46]|abstract[47]	giv[44]|giv[46]|giv[47]	_	_
10-8	697-700	and	abstract[44]|abstract[47]	giv[44]|giv[47]	_	_
10-9	701-707	cancer	abstract[44]|abstract[47]|abstract|abstract[49]	giv[44]|giv[47]|giv|giv[49]	coref|coref|coref|coref	10-34|33-4[191_49]|10-34|33-4[191_49]
10-10	708-712	risk	abstract[44]|abstract[47]|abstract[49]	giv[44]|giv[47]|giv[49]	_	_
10-11	713-716	may	_	_	_	_
10-12	717-719	be	_	_	_	_
10-13	720-729	unrelated	_	_	_	_
10-14	730-732	to	_	_	_	_
10-15	733-737	cell	place|event[52]	new|new[52]	coref|coref	10-22|10-22
10-16	738-746	division	abstract|event[52]	new|new[52]	coref	30-9[178_0]
10-17	747-756	frequency	event[52]	new[52]	_	_
10-18	757-760	and	_	_	_	_
10-19	761-770	resultant	abstract[53]	new[53]	_	_
10-20	771-778	changes	abstract[53]	new[53]	_	_
10-21	779-781	in	abstract[53]	new[53]	_	_
10-22	782-786	cell	abstract[53]|object|quantity[55]	new[53]|giv|new[55]	coref|coref|coref|coref	10-42[60_55]|30-10|10-42[60_55]|30-10
10-23	787-793	number	abstract[53]|quantity[55]	new[53]|new[55]	_	_
10-24	794-795	,	_	_	_	_
10-25	796-798	as	_	_	_	_
10-26	799-804	aptly	_	_	_	_
10-27	805-812	pointed	_	_	_	_
10-28	813-816	out	_	_	_	_
10-29	817-819	by	_	_	_	_
10-30	820-824	Peto	person[56]|abstract[57]	new[56]|new[57]	_	_
10-31	825-827	’s	person[56]|abstract[57]	new[56]|new[57]	_	_
10-32	828-835	paradox	abstract[57]	new[57]	_	_
10-33	836-837	:	_	_	_	_
10-34	838-844	cancer	abstract|abstract[59]	giv|new[59]	coref|coref	11-3|11-3
10-35	845-854	incidence	abstract[59]	new[59]	_	_
10-36	855-859	does	_	_	_	_
10-37	860-863	not	_	_	_	_
10-38	864-870	appear	_	_	_	_
10-39	871-873	to	_	_	_	_
10-40	874-883	correlate	_	_	_	_
10-41	884-888	with	_	_	_	_
10-42	889-892	the	quantity[60]	giv[60]	_	_
10-43	893-899	number	quantity[60]	giv[60]	_	_
10-44	900-902	of	quantity[60]	giv[60]	_	_
10-45	903-908	cells	quantity[60]|object	giv[60]|giv	coref	11-3[67_0]
10-46	909-911	in	_	_	_	_
10-47	912-914	an	animal[62]	new[62]	_	_
10-48	915-923	organism	animal[62]	new[62]	_	_
10-49	924-926	at	animal[62]	new[62]	_	_
10-50	927-930	the	animal[62]|abstract[64]	new[62]|new[64]	_	_
10-51	931-938	species	animal[62]|person|abstract[64]	new[62]|new|new[64]	_	_
10-52	939-944	level	animal[62]|abstract[64]	new[62]|new[64]	_	_
10-53	945-946	.	_	_	_	_

#Text=Mutations in cancer cells are not induced randomly .
11-1	947-956	Mutations	abstract[65]	giv[65]	coref	17-2[107_65]
11-2	957-959	in	abstract[65]	giv[65]	_	_
11-3	960-966	cancer	abstract[65]|abstract|object[67]	giv[65]|giv|giv[67]	coref|coref|coref|coref	17-7|17-7[109_67]|17-7|17-7[109_67]
11-4	967-972	cells	abstract[65]|object[67]	giv[65]|giv[67]	_	_
11-5	973-976	are	_	_	_	_
11-6	977-980	not	_	_	_	_
11-7	981-988	induced	_	_	_	_
11-8	989-997	randomly	_	_	_	_
11-9	998-999	.	_	_	_	_

#Text=Based on whole-genome and exome analyses , chromatin loci with higher mutation levels can be characterized as ( I ) gene loci that are not highly expressed , ( II ) chromosome regions replicating in late S phase , ( III ) heterochromatic loci , and ( IV ) loci with closed chromatin that is not sensitive to DNase I. Mutation rates differ by severalfold between high- and low-mutation loci .
12-1	1000-1005	Based	_	_	_	_
12-2	1006-1008	on	_	_	_	_
12-3	1009-1021	whole-genome	abstract	new	_	_
12-4	1022-1025	and	_	_	_	_
12-5	1026-1031	exome	abstract|abstract[70]	new|new[70]	_	_
12-6	1032-1040	analyses	abstract[70]	new[70]	_	_
12-7	1041-1042	,	_	_	_	_
12-8	1043-1052	chromatin	substance|object[72]	new|new[72]	coref|coref|coref|coref	12-43[80_72]|12-52[82_0]|12-43[80_72]|12-52[82_0]
12-9	1053-1057	loci	object[72]	new[72]	_	_
12-10	1058-1062	with	object[72]	new[72]	_	_
12-11	1063-1069	higher	object[72]|abstract[74]	new[72]|new[74]	_	_
12-12	1070-1078	mutation	object[72]|abstract|abstract[74]	new[72]|giv|new[74]	coref	12-61
12-13	1079-1085	levels	object[72]|abstract[74]	new[72]|new[74]	_	_
12-14	1086-1089	can	_	_	_	_
12-15	1090-1092	be	_	_	_	_
12-16	1093-1106	characterized	_	_	_	_
12-17	1107-1109	as	_	_	_	_
12-18	1110-1111	(	_	_	_	_
12-19	1112-1113	I	abstract	new	_	_
12-20	1114-1115	)	_	_	_	_
12-21	1116-1120	gene	abstract	new	_	_
12-22	1121-1125	loci	_	_	_	_
12-23	1126-1130	that	_	_	_	_
12-24	1131-1134	are	_	_	_	_
12-25	1135-1138	not	_	_	_	_
12-26	1139-1145	highly	_	_	_	_
12-27	1146-1155	expressed	_	_	_	_
12-28	1156-1157	,	_	_	_	_
12-29	1158-1159	(	_	_	_	_
12-30	1160-1162	II	_	_	_	_
12-31	1163-1164	)	_	_	_	_
12-32	1165-1175	chromosome	place	new	_	_
12-33	1176-1183	regions	_	_	_	_
12-34	1184-1195	replicating	_	_	_	_
12-35	1196-1198	in	_	_	_	_
12-36	1199-1203	late	time[78]	new[78]	_	_
12-37	1204-1205	S	time[78]	new[78]	_	_
12-38	1206-1211	phase	time[78]	new[78]	_	_
12-39	1212-1213	,	_	_	_	_
12-40	1214-1215	(	_	_	_	_
12-41	1216-1219	III	person	new	_	_
12-42	1220-1221	)	_	_	_	_
12-43	1222-1237	heterochromatic	object[80]	giv[80]	coref	12-67[88_80]
12-44	1238-1242	loci	object[80]	giv[80]	_	_
12-45	1243-1244	,	object[80]	giv[80]	_	_
12-46	1245-1248	and	object[80]	giv[80]	_	_
12-47	1249-1250	(	object[80]	giv[80]	_	_
12-48	1251-1253	IV	object[80]|person	giv[80]|new	_	_
12-49	1254-1255	)	object[80]	giv[80]	_	_
12-50	1256-1260	loci	object[80]	giv[80]	_	_
12-51	1261-1265	with	_	_	_	_
12-52	1266-1272	closed	substance[82]	giv[82]	_	_
12-53	1273-1282	chromatin	substance[82]	giv[82]	_	_
12-54	1283-1287	that	_	_	_	_
12-55	1288-1290	is	_	_	_	_
12-56	1291-1294	not	_	_	_	_
12-57	1295-1304	sensitive	_	_	_	_
12-58	1305-1307	to	_	_	_	_
12-59	1308-1313	DNase	object|quantity[86]	new|new[86]	coref|coref	29-3[167_86]|29-3[167_86]
12-60	1314-1316	I.	person|quantity[86]	new|new[86]	_	_
12-61	1317-1325	Mutation	abstract|quantity[86]	giv|new[86]	coref	16-1
12-62	1326-1331	rates	quantity[86]	new[86]	_	_
12-63	1332-1338	differ	_	_	_	_
12-64	1339-1341	by	_	_	_	_
12-65	1342-1353	severalfold	_	_	_	_
12-66	1354-1361	between	_	_	_	_
12-67	1362-1367	high-	abstract|object[88]	new|giv[88]	coref|coref	13-20[93_88]|13-20[93_88]
12-68	1368-1371	and	object[88]	giv[88]	_	_
12-69	1372-1384	low-mutation	object[88]	giv[88]	_	_
12-70	1385-1389	loci	object[88]	giv[88]	_	_
12-71	1390-1391	.	_	_	_	_

#Text=Although the source of these differences remains unclear , the phenomenon might be associated with genomic instability , as heterochromatic loci are often subjected to replication stress and chromosomal rearrangements .
13-1	1392-1400	Although	_	_	_	_
13-2	1401-1404	the	abstract[89]	new[89]	_	_
13-3	1405-1411	source	abstract[89]	new[89]	_	_
13-4	1412-1414	of	abstract[89]	new[89]	_	_
13-5	1415-1420	these	abstract[89]|abstract[90]	new[89]|new[90]	_	_
13-6	1421-1432	differences	abstract[89]|abstract[90]	new[89]|new[90]	_	_
13-7	1433-1440	remains	_	_	_	_
13-8	1441-1448	unclear	_	_	_	_
13-9	1449-1450	,	_	_	_	_
13-10	1451-1454	the	abstract[91]	new[91]	_	_
13-11	1455-1465	phenomenon	abstract[91]	new[91]	_	_
13-12	1466-1471	might	_	_	_	_
13-13	1472-1474	be	_	_	_	_
13-14	1475-1485	associated	_	_	_	_
13-15	1486-1490	with	_	_	_	_
13-16	1491-1498	genomic	abstract[92]	new[92]	coref	31-7[184_92]
13-17	1499-1510	instability	abstract[92]	new[92]	_	_
13-18	1511-1512	,	_	_	_	_
13-19	1513-1515	as	_	_	_	_
13-20	1516-1531	heterochromatic	object[93]	giv[93]	_	_
13-21	1532-1536	loci	object[93]	giv[93]	_	_
13-22	1537-1540	are	_	_	_	_
13-23	1541-1546	often	_	_	_	_
13-24	1547-1556	subjected	_	_	_	_
13-25	1557-1559	to	_	_	_	_
13-26	1560-1571	replication	abstract|abstract[95]	giv|new[95]	ana|coref|ana|coref	14-3[0_95]|18-23[114_0]|14-3[0_95]|18-23[114_0]
13-27	1572-1578	stress	abstract[95]	new[95]	_	_
13-28	1579-1582	and	_	_	_	_
13-29	1583-1594	chromosomal	animal|abstract[97]	new|new[97]	_	_
13-30	1595-1609	rearrangements	abstract[97]	new[97]	_	_
13-31	1610-1611	.	_	_	_	_

#Text=Consistent with this , a recent study reported that hypermutation is associated with genomic destabilization .
14-1	1612-1622	Consistent	_	_	_	_
14-2	1623-1627	with	_	_	_	_
14-3	1628-1632	this	abstract	giv	_	_
14-4	1633-1634	,	_	_	_	_
14-5	1635-1636	a	event[99]	new[99]	coref	18-3[111_99]
14-6	1637-1643	recent	event[99]	new[99]	_	_
14-7	1644-1649	study	event[99]	new[99]	_	_
14-8	1650-1658	reported	_	_	_	_
14-9	1659-1663	that	_	_	_	_
14-10	1664-1677	hypermutation	event	giv	coref	20-8
14-11	1678-1680	is	_	_	_	_
14-12	1681-1691	associated	_	_	_	_
14-13	1692-1696	with	_	_	_	_
14-14	1697-1704	genomic	abstract[101]	giv[101]	coref	18-39[118_101]
14-15	1705-1720	destabilization	abstract[101]	giv[101]	_	_
14-16	1721-1722	.	_	_	_	_

#Text=2.2 .
15-1	1723-1726	2.2	abstract	new	_	_
15-2	1727-1728	.	_	_	_	_

#Text=Mutation Induction when Replication-Stress-Associated DSBs Accumulate
16-1	1729-1737	Mutation	abstract|abstract[104]	giv|new[104]	coref|coref|coref|coref	29-5|36-1[208_104]|29-5|36-1[208_104]
16-2	1738-1747	Induction	abstract[104]	new[104]	_	_
16-3	1748-1752	when	_	_	_	_
16-4	1753-1782	Replication-Stress-Associated	abstract|abstract[106]	new|new[106]	coref|coref	18-32[116_106]|18-32[116_106]
16-5	1783-1787	DSBs	abstract[106]	new[106]	_	_
16-6	1788-1798	Accumulate	_	_	_	_

#Text=Among the many mutations induced in cancer cells , somatically-induced replicative mutations are the most prominent .
17-1	1799-1804	Among	_	_	_	_
17-2	1805-1808	the	abstract[107]	giv[107]	coref	17-10[110_107]
17-3	1809-1813	many	abstract[107]	giv[107]	_	_
17-4	1814-1823	mutations	abstract[107]	giv[107]	_	_
17-5	1824-1831	induced	_	_	_	_
17-6	1832-1834	in	_	_	_	_
17-7	1835-1841	cancer	abstract|object[109]	giv|giv[109]	coref|coref|coref|coref	19-9[121_109]|31-20|19-9[121_109]|31-20
17-8	1842-1847	cells	object[109]	giv[109]	_	_
17-9	1848-1849	,	_	_	_	_
17-10	1850-1869	somatically-induced	abstract[110]	giv[110]	coref	18-7[112_110]
17-11	1870-1881	replicative	abstract[110]	giv[110]	_	_
17-12	1882-1891	mutations	abstract[110]	giv[110]	_	_
17-13	1892-1895	are	_	_	_	_
17-14	1896-1899	the	_	_	_	_
17-15	1900-1904	most	_	_	_	_
17-16	1905-1914	prominent	_	_	_	_
17-17	1915-1916	.	_	_	_	_

#Text=Based on a recent study , such replicative mutations can be separated into two types : those induced as random errors during canonical replication , and those induced in association with replication-stress-associated DSBs that accumulate in association with genomic destabilization .
18-1	1917-1922	Based	_	_	_	_
18-2	1923-1925	on	_	_	_	_
18-3	1926-1927	a	abstract[111]	giv[111]	_	_
18-4	1928-1934	recent	abstract[111]	giv[111]	_	_
18-5	1935-1940	study	abstract[111]	giv[111]	_	_
18-6	1941-1942	,	_	_	_	_
18-7	1943-1947	such	abstract[112]	giv[112]	coref	23-3[132_112]
18-8	1948-1959	replicative	abstract[112]	giv[112]	_	_
18-9	1960-1969	mutations	abstract[112]	giv[112]	_	_
18-10	1970-1973	can	_	_	_	_
18-11	1974-1976	be	_	_	_	_
18-12	1977-1986	separated	_	_	_	_
18-13	1987-1991	into	_	_	_	_
18-14	1992-1995	two	abstract[113]	new[113]	_	_
18-15	1996-2001	types	abstract[113]	new[113]	_	_
18-16	2002-2003	:	_	_	_	_
18-17	2004-2009	those	_	_	_	_
18-18	2010-2017	induced	_	_	_	_
18-19	2018-2020	as	_	_	_	_
18-20	2021-2027	random	_	_	_	_
18-21	2028-2034	errors	_	_	_	_
18-22	2035-2041	during	_	_	_	_
18-23	2042-2051	canonical	abstract[114]	giv[114]	coref	19-18[0_114]
18-24	2052-2063	replication	abstract[114]	giv[114]	_	_
18-25	2064-2065	,	_	_	_	_
18-26	2066-2069	and	_	_	_	_
18-27	2070-2075	those	_	_	_	_
18-28	2076-2083	induced	_	_	_	_
18-29	2084-2086	in	_	_	_	_
18-30	2087-2098	association	abstract[115]	giv[115]	coref	18-37[117_115]
18-31	2099-2103	with	abstract[115]	giv[115]	_	_
18-32	2104-2133	replication-stress-associated	abstract[115]|abstract[116]	giv[115]|giv[116]	coref	20-13[0_116]
18-33	2134-2138	DSBs	abstract[115]|abstract[116]	giv[115]|giv[116]	_	_
18-34	2139-2143	that	_	_	_	_
18-35	2144-2154	accumulate	_	_	_	_
18-36	2155-2157	in	_	_	_	_
18-37	2158-2169	association	abstract[117]	giv[117]	coref	20-11[126_117]
18-38	2170-2174	with	abstract[117]	giv[117]	_	_
18-39	2175-2182	genomic	abstract[117]|abstract[118]	giv[117]|giv[118]	coref	20-15[129_118]
18-40	2183-2198	destabilization	abstract[117]|abstract[118]	giv[117]|giv[118]	_	_
18-41	2199-2200	.	_	_	_	_

#Text=Unexpectedly , the former type is relatively rare even in MMR-deficient cells that cannot correct errors during replication .
19-1	2201-2213	Unexpectedly	_	_	_	_
19-2	2214-2215	,	_	_	_	_
19-3	2216-2219	the	abstract[119]	new[119]	_	_
19-4	2220-2226	former	abstract[119]	new[119]	_	_
19-5	2227-2231	type	abstract[119]	new[119]	_	_
19-6	2232-2234	is	_	_	_	_
19-7	2235-2245	relatively	_	_	_	_
19-8	2246-2250	rare	_	_	_	_
19-9	2251-2255	even	object[121]	giv[121]	coref	20-20[0_121]
19-10	2256-2258	in	object[121]	giv[121]	_	_
19-11	2259-2272	MMR-deficient	person|object[121]	new|giv[121]	coref	35-12
19-12	2273-2278	cells	object[121]	giv[121]	_	_
19-13	2279-2283	that	_	_	_	_
19-14	2284-2290	cannot	_	_	_	_
19-15	2291-2298	correct	_	_	_	_
19-16	2299-2305	errors	abstract	giv	coref	29-24[173_0]
19-17	2306-2312	during	_	_	_	_
19-18	2313-2324	replication	abstract	giv	coref	39-21
19-19	2325-2326	.	_	_	_	_

#Text=By contrast , in the latter , hypermutation occurs in association with DSBs and genomic destabilization in barely replicating cells (
20-1	2327-2329	By	_	_	_	_
20-2	2330-2338	contrast	abstract	new	_	_
20-3	2339-2340	,	_	_	_	_
20-4	2341-2343	in	_	_	_	_
20-5	2344-2347	the	_	_	_	_
20-6	2348-2354	latter	_	_	_	_
20-7	2355-2356	,	_	_	_	_
20-8	2357-2370	hypermutation	abstract	giv	_	_
20-9	2371-2377	occurs	_	_	_	_
20-10	2378-2380	in	_	_	_	_
20-11	2381-2392	association	abstract[126]	giv[126]	_	_
20-12	2393-2397	with	abstract[126]	giv[126]	_	_
20-13	2398-2402	DSBs	abstract[126]|abstract|abstract[128]	giv[126]|giv|new[128]	coref|coref|coref|coref	27-3[149_128]|36-11[211_0]|27-3[149_128]|36-11[211_0]
20-14	2403-2406	and	abstract[126]|abstract[128]	giv[126]|new[128]	_	_
20-15	2407-2414	genomic	abstract[126]|abstract[128]|abstract[129]	giv[126]|new[128]|giv[129]	coref	30-20[182_129]
20-16	2415-2430	destabilization	abstract[126]|abstract[128]|abstract[129]	giv[126]|new[128]|giv[129]	_	_
20-17	2431-2433	in	_	_	_	_
20-18	2434-2440	barely	_	_	_	_
20-19	2441-2452	replicating	_	_	_	_
20-20	2453-2458	cells	object	giv	coref	34-1[195_0]
20-21	2459-2460	(	_	_	_	_

#Text=Figure 1
21-1	2461-2467	Figure	object[131]	new[131]	coref	24-1[140_131]
21-2	2468-2469	1	object[131]	new[131]	_	_

#Text=) .
22-1	2470-2471	)	_	_	_	_
22-2	2472-2473	.	_	_	_	_

#Text=Importantly , cancer-driver mutations arise during the latter ; the induced mutations include base substitutions , small insertions and deletions , and large deletions of entire genes (
23-1	2474-2485	Importantly	_	_	_	_
23-2	2486-2487	,	_	_	_	_
23-3	2488-2501	cancer-driver	abstract[132]	giv[132]	coref	23-10[133_132]
23-4	2502-2511	mutations	abstract[132]	giv[132]	_	_
23-5	2512-2517	arise	_	_	_	_
23-6	2518-2524	during	_	_	_	_
23-7	2525-2528	the	_	_	_	_
23-8	2529-2535	latter	_	_	_	_
23-9	2536-2537	;	_	_	_	_
23-10	2538-2541	the	abstract[133]	giv[133]	coref	26-5[142_133]
23-11	2542-2549	induced	abstract[133]	giv[133]	_	_
23-12	2550-2559	mutations	abstract[133]	giv[133]	_	_
23-13	2560-2567	include	_	_	_	_
23-14	2568-2572	base	place|abstract[135]	new|new[135]	_	_
23-15	2573-2586	substitutions	abstract[135]	new[135]	_	_
23-16	2587-2588	,	_	_	_	_
23-17	2589-2594	small	abstract[136]	new[136]	_	_
23-18	2595-2605	insertions	abstract[136]	new[136]	_	_
23-19	2606-2609	and	_	_	_	_
23-20	2610-2619	deletions	event	new	_	_
23-21	2620-2621	,	_	_	_	_
23-22	2622-2625	and	_	_	_	_
23-23	2626-2631	large	abstract[138]	new[138]	coref	40-36[0_138]
23-24	2632-2641	deletions	abstract[138]	new[138]	_	_
23-25	2642-2644	of	abstract[138]	new[138]	_	_
23-26	2645-2651	entire	abstract[138]|abstract[139]	new[138]|new[139]	_	_
23-27	2652-2657	genes	abstract[138]|abstract[139]	new[138]|new[139]	_	_
23-28	2658-2659	(	_	_	_	_

#Text=Figure 1
24-1	2660-2666	Figure	object[140]	giv[140]	_	_
24-2	2667-2668	1	object[140]	giv[140]	_	_

#Text=) .
25-1	2669-2670	)	_	_	_	_
25-2	2671-2672	.	_	_	_	_

#Text=The mechanisms responsible for mutations in this context are not clear , probably because of the presence of repair systems and other related polymerases ( Table 1 ) .
26-1	2673-2676	The	abstract[141]	new[141]	_	_
26-2	2677-2687	mechanisms	abstract[141]	new[141]	_	_
26-3	2688-2699	responsible	abstract[141]	new[141]	_	_
26-4	2700-2703	for	_	_	_	_
26-5	2704-2713	mutations	abstract[142]	giv[142]	coref	30-4[0_142]
26-6	2714-2716	in	abstract[142]	giv[142]	_	_
26-7	2717-2721	this	abstract[142]|abstract[143]	giv[142]|new[143]	_	_
26-8	2722-2729	context	abstract[142]|abstract[143]	giv[142]|new[143]	_	_
26-9	2730-2733	are	_	_	_	_
26-10	2734-2737	not	_	_	_	_
26-11	2738-2743	clear	_	_	_	_
26-12	2744-2745	,	_	_	_	_
26-13	2746-2754	probably	_	_	_	_
26-14	2755-2762	because	_	_	_	_
26-15	2763-2765	of	_	_	_	_
26-16	2766-2769	the	abstract[144]	new[144]	_	_
26-17	2770-2778	presence	abstract[144]	new[144]	_	_
26-18	2779-2781	of	abstract[144]	new[144]	_	_
26-19	2782-2788	repair	abstract[144]|abstract|abstract[146]	new[144]|giv|new[146]	coref|coref	43-10[239_0]|43-10[239_0]
26-20	2789-2796	systems	abstract[144]|abstract[146]	new[144]|new[146]	_	_
26-21	2797-2800	and	abstract[144]	new[144]	_	_
26-22	2801-2806	other	abstract[144]|object[147]	new[144]|giv[147]	coref	27-20[153_147]
26-23	2807-2814	related	abstract[144]|object[147]	new[144]|giv[147]	_	_
26-24	2815-2826	polymerases	abstract[144]|object[147]	new[144]|giv[147]	_	_
26-25	2827-2828	(	_	_	_	_
26-26	2829-2834	Table	object[148]	giv[148]	coref	35-15[207_148]
26-27	2835-2836	1	object[148]	giv[148]	_	_
26-28	2837-2838	)	_	_	_	_
26-29	2839-2840	.	_	_	_	_

#Text=Indeed , these DSBs are generally a target of homologous recombination ( HR ) , which does not involve high-fidelity polymerases ( pols ) δ and ε .
27-1	2841-2847	Indeed	_	_	_	_
27-2	2848-2849	,	_	_	_	_
27-3	2850-2855	these	abstract[149]	giv[149]	coref	27-6[150_149]
27-4	2856-2860	DSBs	abstract[149]	giv[149]	_	_
27-5	2861-2864	are	_	_	_	_
27-6	2865-2874	generally	abstract[150]	giv[150]	coref	39-5[214_150]
27-7	2875-2876	a	abstract[150]	giv[150]	_	_
27-8	2877-2883	target	abstract[150]	giv[150]	_	_
27-9	2884-2886	of	abstract[150]	giv[150]	_	_
27-10	2887-2897	homologous	abstract[150]|abstract[151]	giv[150]|new[151]	appos	27-13[0_151]
27-11	2898-2911	recombination	abstract[150]|abstract[151]	giv[150]|new[151]	_	_
27-12	2912-2913	(	_	_	_	_
27-13	2914-2916	HR	abstract	giv	coref	39-12
27-14	2917-2918	)	_	_	_	_
27-15	2919-2920	,	_	_	_	_
27-16	2921-2926	which	_	_	_	_
27-17	2927-2931	does	_	_	_	_
27-18	2932-2935	not	_	_	_	_
27-19	2936-2943	involve	_	_	_	_
27-20	2944-2957	high-fidelity	object[153]	giv[153]	coref	29-15[170_153]
27-21	2958-2969	polymerases	object[153]	giv[153]	_	_
27-22	2970-2971	(	_	_	_	_
27-23	2972-2976	pols	abstract	new	_	_
27-24	2977-2978	)	_	_	_	_
27-25	2979-2980	δ	abstract|abstract[156]	new|giv[156]	coref|coref	28-10|28-10
27-26	2981-2984	and	abstract[156]	giv[156]	_	_
27-27	2985-2986	ε	abstract[156]|abstract	giv[156]|giv	_	_
27-28	2987-2988	.	_	_	_	_

#Text=Instead , low-fidelity translesion synthesis ( TLS ) polymerases δ , κ , and θ , which synthesize DNA over lesioned templates , are highly expressed .
28-1	2989-2996	Instead	_	_	_	_
28-2	2997-2998	,	_	_	_	_
28-3	2999-3011	low-fidelity	abstract[159]	new[159]	appos	28-7[0_159]
28-4	3012-3023	translesion	abstract|abstract[159]	new|new[159]	coref	29-29
28-5	3024-3033	synthesis	abstract[159]	new[159]	_	_
28-6	3034-3035	(	_	_	_	_
28-7	3036-3039	TLS	abstract	giv	coref	29-11[169_0]
28-8	3040-3041	)	_	_	_	_
28-9	3042-3053	polymerases	_	_	_	_
28-10	3054-3055	δ	abstract	giv	_	_
28-11	3056-3057	,	_	_	_	_
28-12	3058-3059	κ	abstract	new	_	_
28-13	3060-3061	,	_	_	_	_
28-14	3062-3065	and	_	_	_	_
28-15	3066-3067	θ	abstract	new	_	_
28-16	3068-3069	,	_	_	_	_
28-17	3070-3075	which	_	_	_	_
28-18	3076-3086	synthesize	_	_	_	_
28-19	3087-3090	DNA	abstract	new	coref	29-11
28-20	3091-3095	over	_	_	_	_
28-21	3096-3104	lesioned	object[165]	new[165]	_	_
28-22	3105-3114	templates	object[165]	new[165]	_	_
28-23	3115-3116	,	_	_	_	_
28-24	3117-3120	are	_	_	_	_
28-25	3121-3127	highly	_	_	_	_
28-26	3128-3137	expressed	_	_	_	_
28-27	3138-3139	.	_	_	_	_

#Text=Thus , the higher mutation rates are probably due to DNA synthesis performed by these polymerases , which lack proofreading activity , and the errors probably occur during translesion synthesis .
29-1	3140-3144	Thus	_	_	_	_
29-2	3145-3146	,	_	_	_	_
29-3	3147-3150	the	quantity[167]	giv[167]	_	_
29-4	3151-3157	higher	quantity[167]	giv[167]	_	_
29-5	3158-3166	mutation	abstract|quantity[167]	giv|giv[167]	_	_
29-6	3167-3172	rates	quantity[167]	giv[167]	_	_
29-7	3173-3176	are	_	_	_	_
29-8	3177-3185	probably	_	_	_	_
29-9	3186-3189	due	_	_	_	_
29-10	3190-3192	to	_	_	_	_
29-11	3193-3196	DNA	abstract|abstract[169]	giv|giv[169]	coref|coref|coref|coref	29-29[175_169]|47-22|29-29[175_169]|47-22
29-12	3197-3206	synthesis	abstract[169]	giv[169]	_	_
29-13	3207-3216	performed	_	_	_	_
29-14	3217-3219	by	_	_	_	_
29-15	3220-3225	these	object[170]	giv[170]	ana	30-13[0_170]
29-16	3226-3237	polymerases	object[170]	giv[170]	_	_
29-17	3238-3239	,	_	_	_	_
29-18	3240-3245	which	_	_	_	_
29-19	3246-3250	lack	_	_	_	_
29-20	3251-3263	proofreading	object|abstract[172]	giv|new[172]	_	_
29-21	3264-3272	activity	abstract[172]	new[172]	_	_
29-22	3273-3274	,	_	_	_	_
29-23	3275-3278	and	_	_	_	_
29-24	3279-3282	the	abstract[173]	giv[173]	_	_
29-25	3283-3289	errors	abstract[173]	giv[173]	_	_
29-26	3290-3298	probably	_	_	_	_
29-27	3299-3304	occur	_	_	_	_
29-28	3305-3311	during	_	_	_	_
29-29	3312-3323	translesion	abstract|abstract[175]	giv|giv[175]	_	_
29-30	3324-3333	synthesis	abstract[175]	giv[175]	_	_
29-31	3334-3335	.	_	_	_	_

#Text=Thus , while mutations are strongly suppressed during normal cell division , they increase after replication-stress-associated DSB accumulation and genomic destabilization .
30-1	3336-3340	Thus	_	_	_	_
30-2	3341-3342	,	_	_	_	_
30-3	3343-3348	while	_	_	_	_
30-4	3349-3358	mutations	abstract	giv	coref	31-10[185_0]
30-5	3359-3362	are	_	_	_	_
30-6	3363-3371	strongly	_	_	_	_
30-7	3372-3382	suppressed	_	_	_	_
30-8	3383-3389	during	_	_	_	_
30-9	3390-3396	normal	abstract[178]	giv[178]	_	_
30-10	3397-3401	cell	object|abstract[178]	giv|giv[178]	_	_
30-11	3402-3410	division	abstract[178]	giv[178]	_	_
30-12	3411-3412	,	_	_	_	_
30-13	3413-3417	they	object	giv	_	_
30-14	3418-3426	increase	_	_	_	_
30-15	3427-3432	after	_	_	_	_
30-16	3433-3462	replication-stress-associated	abstract[181]	new[181]	_	_
30-17	3463-3466	DSB	abstract|abstract[181]	new|new[181]	coref	43-12
30-18	3467-3479	accumulation	abstract[181]	new[181]	_	_
30-19	3480-3483	and	_	_	_	_
30-20	3484-3491	genomic	abstract[182]	giv[182]	coref	33-7[193_182]
30-21	3492-3507	destabilization	abstract[182]	giv[182]	_	_
30-22	3508-3509	.	_	_	_	_

#Text=Given that most cancers ultimately develop genomic instability , these mutations are most likely the ones that contribute to cancer progression .
31-1	3510-3515	Given	_	_	_	_
31-2	3516-3520	that	_	_	_	_
31-3	3521-3525	most	abstract[183]	new[183]	coref	35-12[206_183]
31-4	3526-3533	cancers	abstract[183]	new[183]	_	_
31-5	3534-3544	ultimately	_	_	_	_
31-6	3545-3552	develop	_	_	_	_
31-7	3553-3560	genomic	abstract[184]	giv[184]	coref	34-10[198_184]
31-8	3561-3572	instability	abstract[184]	giv[184]	_	_
31-9	3573-3574	,	_	_	_	_
31-10	3575-3580	these	abstract[185]	giv[185]	coref	47-13[255_185]
31-11	3581-3590	mutations	abstract[185]	giv[185]	_	_
31-12	3591-3594	are	_	_	_	_
31-13	3595-3599	most	_	_	_	_
31-14	3600-3606	likely	_	_	_	_
31-15	3607-3610	the	abstract[186]	new[186]	_	_
31-16	3611-3615	ones	abstract[186]	new[186]	_	_
31-17	3616-3620	that	_	_	_	_
31-18	3621-3631	contribute	_	_	_	_
31-19	3632-3634	to	_	_	_	_
31-20	3635-3641	cancer	abstract|abstract[188]	giv|new[188]	coref|coref	34-2|34-2
31-21	3642-3653	progression	abstract[188]	new[188]	_	_
31-22	3654-3655	.	_	_	_	_

#Text=2.3 .
32-1	3656-3659	2.3	abstract	new	_	_
32-2	3660-3661	.	_	_	_	_

#Text=Senescence-Associated Increase in the Risk of Genomic Destabilization
33-1	3662-3683	Senescence-Associated	abstract[190]	new[190]	_	_
33-2	3684-3692	Increase	abstract[190]	new[190]	_	_
33-3	3693-3695	in	abstract[190]	new[190]	_	_
33-4	3696-3699	the	abstract[190]|abstract[191]	new[190]|giv[191]	coref	49-13[270_191]
33-5	3700-3704	Risk	abstract[190]|abstract[191]	new[190]|giv[191]	_	_
33-6	3705-3707	of	abstract[190]|abstract[191]	new[190]|giv[191]	_	_
33-7	3708-3715	Genomic	abstract[190]|abstract[191]|abstract|event[193]	new[190]|giv[191]|giv|giv[193]	coref|coref	48-7[261_193]|48-7[261_193]
33-8	3716-3731	Destabilization	abstract[190]|abstract[191]|event[193]	new[190]|giv[191]|giv[193]	_	_

#Text=Most cancer cells develop one of two forms of genomic instability : chromosomal instability ( CIN ) or microsatellite instability ( MSI ) .
34-1	3732-3736	Most	object[195]	giv[195]	coref	48-10[262_195]
34-2	3737-3743	cancer	abstract|object[195]	giv|giv[195]	coref	49-15
34-3	3744-3749	cells	object[195]	giv[195]	_	_
34-4	3750-3757	develop	_	_	_	_
34-5	3758-3761	one	abstract[196]	new[196]	_	_
34-6	3762-3764	of	abstract[196]	new[196]	_	_
34-7	3765-3768	two	abstract[196]|abstract[197]	new[196]|new[197]	appos	34-13[199_197]
34-8	3769-3774	forms	abstract[196]|abstract[197]	new[196]|new[197]	_	_
34-9	3775-3777	of	abstract[196]|abstract[197]	new[196]|new[197]	_	_
34-10	3778-3785	genomic	abstract[196]|abstract[197]|abstract[198]	new[196]|new[197]|giv[198]	coref	34-19[201_198]
34-11	3786-3797	instability	abstract[196]|abstract[197]|abstract[198]	new[196]|new[197]|giv[198]	_	_
34-12	3798-3799	:	_	_	_	_
34-13	3800-3811	chromosomal	abstract[199]	giv[199]	appos	34-16[0_199]
34-14	3812-3823	instability	abstract[199]	giv[199]	_	_
34-15	3824-3825	(	_	_	_	_
34-16	3826-3829	CIN	abstract	giv	coref	35-1
34-17	3830-3831	)	_	_	_	_
34-18	3832-3834	or	_	_	_	_
34-19	3835-3849	microsatellite	abstract[201]	giv[201]	appos	34-22[0_201]
34-20	3850-3861	instability	abstract[201]	giv[201]	_	_
34-21	3862-3863	(	_	_	_	_
34-22	3864-3867	MSI	abstract	giv	coref	35-8
34-23	3868-3869	)	_	_	_	_
34-24	3870-3871	.	_	_	_	_

#Text=CIN is the most frequent , but MSI usually arises in MMR-deficient cancers ( Table 1 ) .
35-1	3872-3875	CIN	abstract	giv	coref	39-1
35-2	3876-3878	is	_	_	_	_
35-3	3879-3882	the	_	_	_	_
35-4	3883-3887	most	_	_	_	_
35-5	3888-3896	frequent	_	_	_	_
35-6	3897-3898	,	_	_	_	_
35-7	3899-3902	but	_	_	_	_
35-8	3903-3906	MSI	abstract	giv	coref	36-7
35-9	3907-3914	usually	_	_	_	_
35-10	3915-3921	arises	_	_	_	_
35-11	3922-3924	in	_	_	_	_
35-12	3925-3938	MMR-deficient	object|abstract[206]	giv|giv[206]	coref|coref	47-1[247_206]|47-1[247_206]
35-13	3939-3946	cancers	abstract[206]	giv[206]	_	_
35-14	3947-3948	(	_	_	_	_
35-15	3949-3954	Table	object[207]	giv[207]	_	_
35-16	3955-3956	1	object[207]	giv[207]	_	_
35-17	3957-3958	)	_	_	_	_
35-18	3959-3960	.	_	_	_	_

#Text=The induction of both CIN and MSI is triggered by replication-stress-associated DSBs (
36-1	3961-3964	The	abstract[208]	giv[208]	_	_
36-2	3965-3974	induction	abstract[208]	giv[208]	_	_
36-3	3975-3977	of	abstract[208]	giv[208]	_	_
36-4	3978-3982	both	abstract[208]|abstract[209]	giv[208]|new[209]	coref	46-3[241_209]
36-5	3983-3986	CIN	abstract[208]|abstract[209]	giv[208]|new[209]	_	_
36-6	3987-3990	and	abstract[208]	giv[208]	_	_
36-7	3991-3994	MSI	abstract[208]|abstract	giv[208]|giv	coref	41-4
36-8	3995-3997	is	_	_	_	_
36-9	3998-4007	triggered	_	_	_	_
36-10	4008-4010	by	_	_	_	_
36-11	4011-4040	replication-stress-associated	abstract[211]	giv[211]	coref	39-18[0_211]
36-12	4041-4045	DSBs	abstract[211]	giv[211]	_	_
36-13	4046-4047	(	_	_	_	_

#Text=Figure 2
37-1	4048-4054	Figure	abstract[212]	new[212]	coref	44-1[240_212]
37-2	4055-4056	2	abstract[212]	new[212]	_	_

#Text=) .
38-1	4057-4058	)	_	_	_	_
38-2	4059-4060	.	_	_	_	_

#Text=CIN often occurs when such DSBs are not effectively repaired by HR , that is , when DSBs arising during replication are carried over into the following G1 phase at a time when HR is not functional .
39-1	4061-4064	CIN	abstract	giv	coref	43-5
39-2	4065-4070	often	_	_	_	_
39-3	4071-4077	occurs	_	_	_	_
39-4	4078-4082	when	_	_	_	_
39-5	4083-4087	such	abstract[214]	giv[214]	coref	46-10[243_214]
39-6	4088-4092	DSBs	abstract[214]	giv[214]	_	_
39-7	4093-4096	are	_	_	_	_
39-8	4097-4100	not	_	_	_	_
39-9	4101-4112	effectively	_	_	_	_
39-10	4113-4121	repaired	_	_	_	_
39-11	4122-4124	by	_	_	_	_
39-12	4125-4127	HR	abstract	giv	coref	39-34
39-13	4128-4129	,	_	_	_	_
39-14	4130-4134	that	_	_	_	_
39-15	4135-4137	is	_	_	_	_
39-16	4138-4139	,	_	_	_	_
39-17	4140-4144	when	_	_	_	_
39-18	4145-4149	DSBs	abstract	giv	coref	40-3[222_0]
39-19	4150-4157	arising	_	_	_	_
39-20	4158-4164	during	_	_	_	_
39-21	4165-4176	replication	abstract	giv	_	_
39-22	4177-4180	are	_	_	_	_
39-23	4181-4188	carried	_	_	_	_
39-24	4189-4193	over	_	_	_	_
39-25	4194-4198	into	_	_	_	_
39-26	4199-4202	the	time[219]	new[219]	_	_
39-27	4203-4212	following	time[219]	new[219]	_	_
39-28	4213-4215	G1	place|time[219]	new|new[219]	_	_
39-29	4216-4221	phase	time[219]	new[219]	_	_
39-30	4222-4224	at	_	_	_	_
39-31	4225-4226	a	time[220]	new[220]	_	_
39-32	4227-4231	time	time[220]	new[220]	_	_
39-33	4232-4236	when	_	_	_	_
39-34	4237-4239	HR	time	giv	_	_
39-35	4240-4242	is	_	_	_	_
39-36	4243-4246	not	_	_	_	_
39-37	4247-4257	functional	_	_	_	_
39-38	4258-4259	.	_	_	_	_

#Text=Consequently , the DSBs are often erroneously ligated by non-homologous end joining ( NHEJ ) with topologically incorrect broken ends , resulting in a background that causes CIN-associated chromosomal alterations such as chromosomal translocations , deletions , and rearrangements .
40-1	4260-4272	Consequently	_	_	_	_
40-2	4273-4274	,	_	_	_	_
40-3	4275-4278	the	abstract[222]	giv[222]	coref	41-7[233_222]
40-4	4279-4283	DSBs	abstract[222]	giv[222]	_	_
40-5	4284-4287	are	_	_	_	_
40-6	4288-4293	often	_	_	_	_
40-7	4294-4305	erroneously	_	_	_	_
40-8	4306-4313	ligated	_	_	_	_
40-9	4314-4316	by	_	_	_	_
40-10	4317-4331	non-homologous	event[223]	new[223]	coref	41-15[234_223]
40-11	4332-4335	end	event[223]	new[223]	_	_
40-12	4336-4343	joining	_	_	_	_
40-13	4344-4345	(	_	_	_	_
40-14	4346-4350	NHEJ	abstract	new	_	_
40-15	4351-4352	)	_	_	_	_
40-16	4353-4357	with	_	_	_	_
40-17	4358-4371	topologically	abstract[225]	new[225]	_	_
40-18	4372-4381	incorrect	abstract[225]	new[225]	_	_
40-19	4382-4388	broken	abstract[225]	new[225]	_	_
40-20	4389-4393	ends	abstract[225]	new[225]	_	_
40-21	4394-4395	,	_	_	_	_
40-22	4396-4405	resulting	_	_	_	_
40-23	4406-4408	in	_	_	_	_
40-24	4409-4410	a	abstract[226]	new[226]	coref	47-17[254_226]
40-25	4411-4421	background	abstract[226]	new[226]	_	_
40-26	4422-4426	that	_	_	_	_
40-27	4427-4433	causes	_	_	_	_
40-28	4434-4448	CIN-associated	abstract[228]	new[228]	_	_
40-29	4449-4460	chromosomal	place|abstract[228]	new|new[228]	_	_
40-30	4461-4472	alterations	abstract[228]	new[228]	_	_
40-31	4473-4477	such	abstract[228]	new[228]	_	_
40-32	4478-4480	as	abstract[228]	new[228]	_	_
40-33	4481-4492	chromosomal	abstract[228]|abstract[229]	new[228]|new[229]	_	_
40-34	4493-4507	translocations	abstract[228]|abstract[229]	new[228]|new[229]	_	_
40-35	4508-4509	,	abstract[228]	new[228]	_	_
40-36	4510-4519	deletions	abstract[228]|abstract	new[228]|giv	_	_
40-37	4520-4521	,	abstract[228]	new[228]	_	_
40-38	4522-4525	and	abstract[228]	new[228]	_	_
40-39	4526-4540	rearrangements	abstract[228]|event	new[228]|new	_	_
40-40	4541-4542	.	_	_	_	_

#Text=By contrast , MSI arises when those DSBs are effectively but erroneously repaired by microhomology-mediated end joining ( MMEJ ; also known as alternative end joining ) (
41-1	4543-4545	By	_	_	_	_
41-2	4546-4554	contrast	_	_	_	_
41-3	4555-4556	,	_	_	_	_
41-4	4557-4560	MSI	abstract	giv	coref	46-6
41-5	4561-4567	arises	_	_	_	_
41-6	4568-4572	when	_	_	_	_
41-7	4573-4578	those	abstract[233]	giv[233]	_	_
41-8	4579-4583	DSBs	abstract[233]	giv[233]	_	_
41-9	4584-4587	are	_	_	_	_
41-10	4588-4599	effectively	_	_	_	_
41-11	4600-4603	but	_	_	_	_
41-12	4604-4615	erroneously	_	_	_	_
41-13	4616-4624	repaired	_	_	_	_
41-14	4625-4627	by	_	_	_	_
41-15	4628-4650	microhomology-mediated	event[234]	giv[234]	_	_
41-16	4651-4654	end	event[234]	giv[234]	_	_
41-17	4655-4662	joining	_	_	_	_
41-18	4663-4664	(	_	_	_	_
41-19	4665-4669	MMEJ	object	new	_	_
41-20	4670-4671	;	_	_	_	_
41-21	4672-4676	also	_	_	_	_
41-22	4677-4682	known	_	_	_	_
41-23	4683-4685	as	_	_	_	_
41-24	4686-4697	alternative	_	_	_	_
41-25	4698-4701	end	_	_	_	_
41-26	4702-4709	joining	_	_	_	_
41-27	4710-4711	)	_	_	_	_
41-28	4712-4713	(	_	_	_	_

#Text=Figure 3
42-1	4714-4720	Figure	abstract[236]	new[236]	_	_
42-2	4721-4722	3	abstract[236]	new[236]	_	_

#Text=) , during which CIN is suppressed because of the resultant DSB repair (
43-1	4723-4724	)	_	_	_	_
43-2	4725-4726	,	_	_	_	_
43-3	4727-4733	during	_	_	_	_
43-4	4734-4739	which	_	_	_	_
43-5	4740-4743	CIN	abstract	giv	coref	47-4[249_0]
43-6	4744-4746	is	_	_	_	_
43-7	4747-4757	suppressed	_	_	_	_
43-8	4758-4765	because	_	_	_	_
43-9	4766-4768	of	_	_	_	_
43-10	4769-4772	the	abstract[239]	giv[239]	coref	46-18[245_239]
43-11	4773-4782	resultant	abstract[239]	giv[239]	_	_
43-12	4783-4786	DSB	abstract|abstract[239]	giv|giv[239]	coref	47-10
43-13	4787-4793	repair	abstract[239]	giv[239]	_	_
43-14	4794-4795	(	_	_	_	_

#Text=Figure 2
44-1	4796-4802	Figure	abstract[240]	giv[240]	_	_
44-2	4803-4804	2	abstract[240]	giv[240]	_	_

#Text=) .
45-1	4805-4806	)	_	_	_	_
45-2	4807-4808	.	_	_	_	_

#Text=Thus , both CIN and MSI are triggered by replication-stress-associated DSBs and arise due to abnormalities in the repair of these lesions .
46-1	4809-4813	Thus	_	_	_	_
46-2	4814-4815	,	_	_	_	_
46-3	4816-4820	both	abstract[241]	giv[241]	_	_
46-4	4821-4824	CIN	abstract[241]	giv[241]	_	_
46-5	4825-4828	and	_	_	_	_
46-6	4829-4832	MSI	abstract	giv	coref	47-4[248_0]
46-7	4833-4836	are	_	_	_	_
46-8	4837-4846	triggered	_	_	_	_
46-9	4847-4849	by	_	_	_	_
46-10	4850-4879	replication-stress-associated	abstract[243]	giv[243]	coref	50-3[271_243]
46-11	4880-4884	DSBs	abstract[243]	giv[243]	_	_
46-12	4885-4888	and	_	_	_	_
46-13	4889-4894	arise	_	_	_	_
46-14	4895-4898	due	_	_	_	_
46-15	4899-4901	to	_	_	_	_
46-16	4902-4915	abnormalities	abstract[244]	new[244]	coref	47-8[250_244]
46-17	4916-4918	in	abstract[244]	new[244]	_	_
46-18	4919-4922	the	abstract[244]|abstract[245]	new[244]|giv[245]	coref	47-10[252_245]
46-19	4923-4929	repair	abstract[244]|abstract[245]	new[244]|giv[245]	_	_
46-20	4930-4932	of	abstract[244]|abstract[245]	new[244]|giv[245]	_	_
46-21	4933-4938	these	abstract[244]|abstract[245]|abstract[246]	new[244]|giv[245]|new[246]	_	_
46-22	4939-4946	lesions	abstract[244]|abstract[245]|abstract[246]	new[244]|giv[245]|new[246]	_	_
46-23	4947-4948	.	_	_	_	_

#Text=Most cancers develop genomic instability due to abnormalities in DSB repair ; paradoxically , however , most lack background mutations in DNA repair systems .
47-1	4949-4953	Most	abstract[247]	giv[247]	_	_
47-2	4954-4961	cancers	abstract[247]	giv[247]	_	_
47-3	4962-4969	develop	_	_	_	_
47-4	4970-4977	genomic	abstract[248]|abstract[249]	giv[248]|giv[249]	_	_
47-5	4978-4989	instability	abstract[248]|abstract[249]	giv[248]|giv[249]	_	_
47-6	4990-4993	due	abstract[248]|abstract[249]	giv[248]|giv[249]	_	_
47-7	4994-4996	to	abstract[248]|abstract[249]	giv[248]|giv[249]	_	_
47-8	4997-5010	abnormalities	abstract[248]|abstract[249]|abstract[250]	giv[248]|giv[249]|giv[250]	_	_
47-9	5011-5013	in	abstract[248]|abstract[249]|abstract[250]	giv[248]|giv[249]|giv[250]	_	_
47-10	5014-5017	DSB	abstract[248]|abstract[249]|abstract[250]|abstract|abstract[252]	giv[248]|giv[249]|giv[250]|giv|giv[252]	coref|coref|coref|coref	47-23[0_252]|51-13|47-23[0_252]|51-13
47-11	5018-5024	repair	abstract[248]|abstract[249]|abstract[250]|abstract[252]	giv[248]|giv[249]|giv[250]|giv[252]	_	_
47-12	5025-5026	;	abstract[249]	giv[249]	_	_
47-13	5027-5040	paradoxically	abstract[249]|abstract[255]	giv[249]|giv[255]	_	_
47-14	5041-5042	,	abstract[249]|abstract[255]	giv[249]|giv[255]	_	_
47-15	5043-5050	however	abstract[249]|abstract[255]	giv[249]|giv[255]	_	_
47-16	5051-5052	,	abstract[249]|abstract[255]	giv[249]|giv[255]	_	_
47-17	5053-5057	most	abstract[249]|abstract[253]|abstract[254]|abstract[255]	giv[249]|new[253]|giv[254]|giv[255]	_	_
47-18	5058-5062	lack	abstract[249]|abstract[253]|abstract[254]|abstract[255]	giv[249]|new[253]|giv[254]|giv[255]	_	_
47-19	5063-5073	background	abstract[249]|abstract[254]|abstract[255]	giv[249]|giv[254]|giv[255]	_	_
47-20	5074-5083	mutations	abstract[249]|abstract[255]	giv[249]|giv[255]	_	_
47-21	5084-5086	in	abstract[249]|abstract[255]	giv[249]|giv[255]	_	_
47-22	5087-5090	DNA	abstract[249]|abstract[255]|abstract|abstract[258]	giv[249]|giv[255]|giv|new[258]	coref|coref|coref|coref	48-23|48-22[266_258]|48-23|48-22[266_258]
47-23	5091-5097	repair	abstract[249]|abstract[255]|abstract|abstract[258]	giv[249]|giv[255]|giv|new[258]	ana	48-1
47-24	5098-5105	systems	abstract[249]|abstract[255]|abstract[258]	giv[249]|giv[255]|new[258]	_	_
47-25	5106-5107	.	_	_	_	_

#Text=This raises the question of how genomic destabilization occurs even in normal cells , that is , genetically normal cells with functional DNA repair systems .
48-1	5108-5112	This	abstract	giv	coref	48-24
48-2	5113-5119	raises	_	_	_	_
48-3	5120-5123	the	abstract[260]	new[260]	_	_
48-4	5124-5132	question	abstract[260]	new[260]	_	_
48-5	5133-5135	of	abstract[260]	new[260]	_	_
48-6	5136-5139	how	abstract[260]	new[260]	_	_
48-7	5140-5147	genomic	event[261]	giv[261]	_	_
48-8	5148-5163	destabilization	event[261]	giv[261]	_	_
48-9	5164-5170	occurs	_	_	_	_
48-10	5171-5175	even	object[262]	giv[262]	coref	48-18[263_262]
48-11	5176-5178	in	object[262]	giv[262]	_	_
48-12	5179-5185	normal	object[262]	giv[262]	_	_
48-13	5186-5191	cells	object[262]	giv[262]	_	_
48-14	5192-5193	,	_	_	_	_
48-15	5194-5198	that	_	_	_	_
48-16	5199-5201	is	_	_	_	_
48-17	5202-5203	,	_	_	_	_
48-18	5204-5215	genetically	object[263]	giv[263]	coref	51-5[0_263]
48-19	5216-5222	normal	object[263]	giv[263]	_	_
48-20	5223-5228	cells	object[263]	giv[263]	_	_
48-21	5229-5233	with	object[263]	giv[263]	_	_
48-22	5234-5244	functional	object[263]|abstract[266]	giv[263]|giv[266]	_	_
48-23	5245-5248	DNA	object[263]|abstract|abstract[266]	giv[263]|giv|giv[266]	_	_
48-24	5249-5255	repair	object[263]|abstract|abstract[266]	giv[263]|giv|giv[266]	_	_
48-25	5256-5263	systems	object[263]|abstract[266]	giv[263]|giv[266]	_	_
48-26	5264-5265	.	_	_	_	_

#Text=This phenomenon is probably associated with age , which is associated with an elevated cancer risk .
49-1	5266-5270	This	abstract[267]	new[267]	_	_
49-2	5271-5281	phenomenon	abstract[267]	new[267]	_	_
49-3	5282-5284	is	_	_	_	_
49-4	5285-5293	probably	_	_	_	_
49-5	5294-5304	associated	_	_	_	_
49-6	5305-5309	with	_	_	_	_
49-7	5310-5313	age	abstract	new	coref	50-10[273_0]
49-8	5314-5315	,	_	_	_	_
49-9	5316-5321	which	_	_	_	_
49-10	5322-5324	is	_	_	_	_
49-11	5325-5335	associated	_	_	_	_
49-12	5336-5340	with	_	_	_	_
49-13	5341-5343	an	abstract[270]	giv[270]	_	_
49-14	5344-5352	elevated	abstract[270]	giv[270]	_	_
49-15	5353-5359	cancer	abstract|abstract[270]	giv|giv[270]	_	_
49-16	5360-5364	risk	abstract[270]	giv[270]	_	_
49-17	5365-5366	.	_	_	_	_

#Text=Indeed , irreparable DSBs accumulate widely in association with age in vivo and passage in vitro .
50-1	5367-5373	Indeed	_	_	_	_
50-2	5374-5375	,	_	_	_	_
50-3	5376-5387	irreparable	abstract[271]	giv[271]	_	_
50-4	5388-5392	DSBs	abstract[271]	giv[271]	_	_
50-5	5393-5403	accumulate	_	_	_	_
50-6	5404-5410	widely	_	_	_	_
50-7	5411-5413	in	_	_	_	_
50-8	5414-5425	association	abstract[272]	new[272]	_	_
50-9	5426-5430	with	abstract[272]	new[272]	_	_
50-10	5431-5434	age	abstract[272]|abstract[273]	new[272]|giv[273]	ana	51-3[0_273]
50-11	5435-5437	in	abstract[272]|abstract[273]	new[272]|giv[273]	_	_
50-12	5438-5442	vivo	abstract[272]|abstract[273]	new[272]|giv[273]	_	_
50-13	5443-5446	and	abstract[272]|abstract[273]	new[272]|giv[273]	_	_
50-14	5447-5454	passage	abstract[272]|abstract[273]|place[274]	new[272]|giv[273]|new[274]	_	_
50-15	5455-5457	in	abstract[272]|abstract[273]|place[274]	new[272]|giv[273]|new[274]	_	_
50-16	5458-5463	vitro	abstract[272]|abstract[273]|place[274]	new[272]|giv[273]|new[274]	_	_
50-17	5464-5465	.	_	_	_	_

#Text=Consistent with this , cells often undergo senescence as a consequence of DSB accumulation .
51-1	5466-5476	Consistent	_	_	_	_
51-2	5477-5481	with	_	_	_	_
51-3	5482-5486	this	abstract	giv	_	_
51-4	5487-5488	,	_	_	_	_
51-5	5489-5494	cells	object	giv	_	_
51-6	5495-5500	often	_	_	_	_
51-7	5501-5508	undergo	_	_	_	_
51-8	5509-5519	senescence	abstract	new	_	_
51-9	5520-5522	as	_	_	_	_
51-10	5523-5524	a	_	_	_	_
51-11	5525-5536	consequence	_	_	_	_
51-12	5537-5539	of	_	_	_	_
51-13	5540-5543	DSB	abstract|abstract[279]	giv|new[279]	coref|coref|coref|coref	52-5|52-5[282_279]|52-5|52-5[282_279]
51-14	5544-5556	accumulation	abstract[279]	new[279]	_	_
51-15	5557-5558	.	_	_	_	_

#Text=Although the reasons for DSB accumulation are not clear , they are likely to include a reduction in histone H2AX , which mediates repair-factor recruitment and is required for genome stability .
52-1	5559-5567	Although	_	_	_	_
52-2	5568-5571	the	abstract[280]	new[280]	ana	52-11[0_280]
52-3	5572-5579	reasons	abstract[280]	new[280]	_	_
52-4	5580-5583	for	abstract[280]	new[280]	_	_
52-5	5584-5587	DSB	abstract[280]|abstract|abstract[282]	new[280]|giv|giv[282]	_	_
52-6	5588-5600	accumulation	abstract[280]|abstract[282]	new[280]|giv[282]	_	_
52-7	5601-5604	are	_	_	_	_
52-8	5605-5608	not	_	_	_	_
52-9	5609-5614	clear	_	_	_	_
52-10	5615-5616	,	_	_	_	_
52-11	5617-5621	they	abstract	giv	_	_
52-12	5622-5625	are	_	_	_	_
52-13	5626-5632	likely	_	_	_	_
52-14	5633-5635	to	_	_	_	_
52-15	5636-5643	include	_	_	_	_
52-16	5644-5645	a	abstract[284]	new[284]	_	_
52-17	5646-5655	reduction	abstract[284]	new[284]	_	_
52-18	5656-5658	in	abstract[284]	new[284]	_	_
52-19	5659-5666	histone	abstract[284]|substance|abstract[286]	new[284]|new|new[286]	_	_
52-20	5667-5671	H2AX	abstract[284]|abstract[286]	new[284]|new[286]	_	_
52-21	5672-5673	,	_	_	_	_
52-22	5674-5679	which	_	_	_	_
52-23	5680-5688	mediates	_	_	_	_
52-24	5689-5702	repair-factor	abstract[287]	new[287]	_	_
52-25	5703-5714	recruitment	abstract[287]	new[287]	_	_
52-26	5715-5718	and	_	_	_	_
52-27	5719-5721	is	_	_	_	_
52-28	5722-5730	required	_	_	_	_
52-29	5731-5734	for	_	_	_	_
52-30	5735-5741	genome	abstract|abstract[289]	new|new[289]	_	_
52-31	5742-5751	stability	abstract[289]	new[289]	_	_
52-32	5752-5753	.	_	_	_	_
